Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas

著者: Kevin J. Harrington, Joshua Brody, M. Ingham, James Strauss, Sašo Čemerski, M. Wang, Archie Tse, Anuradha Khilnani, Aurélien Marabelle, Talia Golan - Annals of Oncology 2018 被引用: 276